Intellectual Property Archive » October, 2005

Intellectual Property - October, 2005

115 articles

• Supreme Court Rebuffs Solicitor General, Takes LabCorp Case
• Sonnenschein Names New Head Of IP Group
• In Setback for Glaxo, U.K. Invalidates Paxil Patent
• Lawsuits Make Company Worth More Dead Than Alive
• Supreme Court Denies Microsoft Appeal In $561M Case
• Refco IP Auction: Patent Attorneys Say "Not So Fast"
• Forgent, BlackBerry Maker Ink Licensing Pact
• Acacia Targets Heavy Industry With New Patent
• Patent Fight Over Microscope Gear Trudges On
• Historians Sue Dan Brown Over "Da Vinci Code"
• Qualcomm Licensing "Abusive," High-Tech Rivals Say
• VP-Turned-Rival Infringed Patents, Stole Secrets: Suit
• Inventor Infringed Own Patent, Federal Circuit Rules
• Robins Kaplan Hires Co-Founder Of Atlanta Boutique
• Magma Countersues Synopsys Over Chip Designs
• How A Chief Intellectual Property Officer Can Strengthen Your M&A Activity
• Connetics Files Suit Over Agis ANDA
• Sun Pharma Takes Unique Road To Victory Vs. J&J
• LED Suit Dismissed Over 14-Month Delay In Filing
• Web Analysis Companies Settle Patent Suit
• CAT And Abbott Settle Humira Royalties Dispute
• RIM Reels From Supreme Court Denial Of Stay
• Congress Should Tackle Google Library, Group Urges
• Fujitsu, NEC, Toshiba, Matsushita Sued Over Chip Patents
• Eye Care Rivals Face Threat From IP Holding Company
• IBM Opens Patent Trove To Healthcare Industry
• In Risky Strategy, BlackBerry Maker To Fight Stay
• Cheaper, Faster Appeal Of Claims Rejections At USPTO
• Merchant & Gould To Merge With Welsh & Katz
• Market Exclusivity "Give-Away" Gone In Bioterror Bill
• Two Firms Fight Over Foley Service Mark
• LCD Glass Makers Settle Copyright, Trade Secrets Suits
• Court Blasts FDA Over Pravachol Generic Launch
• Shire Sues Barr, Impax Again Over Adderall Patents
• What "Lundgren" Means To Business Method Patents
• Texas Challenges California As IP Litigation Hotbed
• MediaTek, Matsushita Face Off In Second Suit
• Ralph Lauren Loses Polo Match
• Stanford Sues Roche Over HIV Monitoring Technology
• Copyright Litigation Soars, But Fewer Sue Over Patents
• Intel To Pay $300M To Settle Chip Patent Suit
• Publishers Sue To Clarify Fair Use In Google Project
• WebEx Sued Over Internet Meeting Technology
• Complying With License, MedImmune Loses Case
• Federal Circuit Tosses Sicom Suit For Lack Of Standing
• J&J Suffers Headache Over Migraine Generic
• Prosecution Laches As A Defense In Patent Cases
• Foley & Lardner Hires Top Entertainment Litigator
• Biovail Files 2nd Suit To Protect Blood Pressure Drug
• Roche Mulls Sub-Licensing Bird Flu Drug
• Hamilton Brook Hires Veteran Sonnenschein Litigator
• Wyeth, Teva Strike Deal On Antidepressant Generic
• Rambus "Shred Days" To Resurface In Hynix Trial
• Toshiba Files New Chip Suit Against Hynix
• Attorneys Eye "Tidal Wave" Of Biz Method Patents
• Bioterrorism Defense Bill Could Change Patent Law
• Sony, Immersion Back In Court Over Misconduct Claims
• Ranbaxy, AstraZeneca Battle Looms Over Ulcer Drug
• Setback For Google In Microsoft Trade-Secrets Case
• Injunction Imperils bcgi In Prepaid Wireless Case
• Superior Court Finalizes $465M Victory For Lexar
• Acacia, Universities Close To Deal On Internet Patent
• Gemstar Sues Over Patent For Online TV Listings
• Supreme Court Lets Merck Loss In Fosamax Case Stand
• J&J Challenged Over Schizophrenia Drug Patent
• Company Paid Students To Steal SATs, Suit Claims
• Indian Drug Company To Copy Roche Flu Drug
• J&J Loses Dutch Stent Trial Against Boston Scientific
• F&R Beats McDermott, Foley As Top Patent Litigator
• University Sees Cash Cow In Text Messaging Patent
• With An Eye On IP, Duane Morris Shakes Up Big Boys
• Hatch Eyes FDA For Move On Generic Biologics
• Check Technology Case Stays In Texas
• Biotech Companies Clash Over HPV, HCV Patents
• Supreme Court Lets Stand Landmark Drug Ruling
• Biotech Rivals Settle Suit Over Cancer Research Yeast
• E.U. Calls For Self-Regulated Music Royalties System
• U.K. Upholds One Lipitor Patent, Invalidates Another
• Biotech Litigators Leave Orrick To Join Sidley
• Jilted Ranbaxy Sues Barr, Teva Over Allegra Generic
• Patent Pendency Not Improving, USPTO Admits
• Court Slams IXYS With Damages In Chip Patent Case
• Tech Giants Clash Over MP3 Licensing Deals
• U.K. To Decide On Lipitor Patent Wednesday
• E.U. Move Raises Ire Of Software Patent Foes
• Supreme Court Next Stop For BlackBerry Patent War
• IBM Drops Countersuit In SCO Linux Case
• Patent Reform To Slash Litigation Costs, IPO Says
• WIPO Summit Leaves Deep Split Unbridged
• Ricoh Settles Patent Suit Over CD, DVD Technologies
• Novo Nordisk Misled USPTO, Federal Circuit Rules
• Alphapharm Concedes To Forest Labs In Antidepressant Battle
• USPTO Rejects Microsoft Computer File Patents
• Invitrogen V. Stratagene Remanded Again
• Medtronic Awarded $51 Million in BrainLab Suit
• Federal Circuit Rules For Earth Resource In Lizardtech Appeal
• In Unusal Twist, Defendant Appeals Dismissal Of Biotech Patent Lawsuit
• Yahoo Braves Murky Waters To Create Online Library
• Sprint, Vonage Clash Over Voice Over Packet Technology
• Howrey Hires IP Litigator From Morrison & Foerster
• Acacia In New Deal With AMD Over Bar-Code Patents
• Federal Circuit Overturns Injunction Against Medtronic
• Video Game Accessory Infringes With New Claims Construction, Federal Circuit Rules
• Second ITC Defeat For MediaTek in Zoran Case
• Viewpointe Files Countersuit In Electronic Check Case
• Patent Suit Dropped After Supreme Court "Safe Harbor" Ruling
• Supreme Court Deals Final Blow To University In LCD Patent Suit
• Compromise Patent Reform Bill Still A Step Forward, Sponsor Insists
• Sughrue Mion Hires IP Veterans From Silicon Valley High-Tech Companies
• Toshiba Slaps Hynix With Another Patent Infringement Suit
• Smith & Nephew, ArthroCare Settle Patent Suit Over Surgical Devices
• In Unusual Step, U.K. Patent Office Begins Issuing Non-Binding Opinions On Patent Validity
• ThinkFire Launches Patent Brokerage Division
• After 13 Years, Medical Device Makers Pen $75M Settlement
• Enzo Patent Invalid Due To Sale Of Technology Prior To Issuance